![](https://endpts.com/wp-content/uploads/2020/12/Carl-Hansen-AbCellera-tile-scaled.jpg)
Carl Hansen, AbCellera CEO
AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research
AbCellera, a Vancouver-based antibody manufacturer, received an investment from the government of Canada and the province of British Columbia.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.